Quarterly report pursuant to Section 13 or 15(d)

Loss Per Common Share (Details)

v3.7.0.1
Loss Per Common Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Mar. 31, 2017
Mar. 31, 2016
Basic and diluted numerator:        
Net loss available to iBio, Inc. stockholders $ (3,939) $ (3,036) $ (10,229) $ (7,087)
Net loss attributable to iBio, Inc. (3,913) (3,036) (10,203) (7,087)
Preferred stock dividends $ 26 $ 0 $ 26 $ 0
Basic and diluted denominator:        
Weighted-average common shares outstanding 89,109 81,158 89,109 78,587
Per share amount $ (0.04) $ (0.04) $ (0.11) $ (0.09)